Annual CFF
$10.25 M
-$6.14 M-37.45%
30 June 2024
Summary:
Renalytix annual cash flow from financing activities is currently $10.25 million, with the most recent change of -$6.14 million (-37.45%) on 30 June 2024. During the last 3 years, it has fallen by -$66.99 million (-86.73%). RNLX annual CFF is now -86.73% below its all-time high of $77.24 million, reached on 30 June 2021.RNLX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
30 September 2024
Summary:
Renalytix quarterly cash flow from financing activities is not available.RNLX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
30 September 2024
Summary:
Renalytix TTM cash flow from financing activities is not available.RNLX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.5% | - | - |
| 3 y3 years | -86.7% | - | - |
| 5 y5 years | -62.6% | - | - |
RNLX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -86.7% | at low | ||||
| 5 y | 5 years | -86.7% | at low | ||||
| alltime | all time | -86.7% | at low |
Renalytix Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | $10.25 M(-37.4%) | $7.79 M(+89.3%) | $10.25 M(+333.8%) |
| Mar 2024 | - | $4.11 M(-799.7%) | $2.36 M(-85.5%) |
| Dec 2023 | - | -$588.00 K(-44.8%) | $16.35 M(+0.5%) |
| Sept 2023 | - | -$1.06 M(+986.7%) | $16.27 M(-0.7%) |
| June 2023 | $16.39 M(-36.1%) | -$98.00 K(-100.5%) | $16.39 M(-60.8%) |
| Mar 2023 | - | $18.10 M(-2801.2%) | $41.80 M(+76.4%) |
| Dec 2022 | - | -$670.00 K(-29.0%) | $23.70 M(-3.2%) |
| Sept 2022 | - | -$944.00 K(-103.7%) | $24.48 M(-4.5%) |
| June 2022 | $25.63 M | $25.31 M(>+9900.0%) | $25.63 M(+4412.3%) |
| Mar 2022 | - | $0.00(-100.0%) | $568.00 K(-16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $111.00 K(-46.1%) | $679.00 K(+19.8%) |
| Sept 2021 | - | $206.00 K(-17.9%) | $567.00 K(-99.3%) |
| June 2021 | $77.24 M(+384.6%) | $251.00 K(+126.1%) | $77.24 M(+0.9%) |
| Mar 2021 | - | $111.00 K(<-9900.0%) | $76.54 M(+0.2%) |
| Dec 2020 | - | -$1000.00(-100.0%) | $76.39 M(-0.0%) |
| Sept 2020 | - | $76.88 M(<-9900.0%) | $76.39 M(+379.3%) |
| June 2020 | $15.94 M(-41.8%) | -$446.00 K(+987.8%) | $15.94 M(-2.7%) |
| Mar 2020 | - | -$41.00 K(<-9900.0%) | $16.38 M(-0.2%) |
| Dec 2019 | - | $0.00(-100.0%) | $16.43 M(0.0%) |
| Sept 2019 | - | $16.43 M | $16.43 M |
| June 2019 | $27.38 M | - | - |
FAQ
- What is Renalytix annual cash flow from financing activities?
- What is the all time high annual CFF for Renalytix?
- What is Renalytix annual CFF year-on-year change?
- What is the all time high quarterly CFF for Renalytix?
- What is the all time high TTM CFF for Renalytix?
What is Renalytix annual cash flow from financing activities?
The current annual CFF of RNLX is $10.25 M
What is the all time high annual CFF for Renalytix?
Renalytix all-time high annual cash flow from financing activities is $77.24 M
What is Renalytix annual CFF year-on-year change?
Over the past year, RNLX annual cash flow from financing activities has changed by -$6.14 M (-37.45%)
What is the all time high quarterly CFF for Renalytix?
Renalytix all-time high quarterly cash flow from financing activities is $76.88 M
What is the all time high TTM CFF for Renalytix?
Renalytix all-time high TTM cash flow from financing activities is $77.24 M